theheart.org: Thrombosis Risk news and education

Thrombosis Risk

Advancing Anticoagulation in Cardiovascular Medicine: Perspectives on Future Oral Therapies

3 COMMENTS - Jul 31, 2009 11:00 EDT

The treatment options for oral anticoagulation therapy are constantly evolving. Join our expert panel, Drs. Graham Turpie, Jessica L. Mega, Jeffrey Weitz, as they discuss the new data and clinical implications of new anticoagulant medications for patients with ACS

Thrombosis Risk

Total Joint Arthroplasty: Cutting Edge Developments in the Prevention of Thromboembolism

Jan 12, 2009 13:55 EST

The balancing act: How can we best protect patients from thromboembolic complications after major orthopaedic surgery without increasing the risk of bleeding? Drs Caprini, Maloney, and Barnes discuss management strategies and unmet needs in treatment options.

Thrombosis Risk

Warfarin and Beyond: Evolution of Anticoagulation Therapies

17 COMMENTS - Dec 29, 2008 15:45 EST

Where do the new and emerging oral anticoagulants target the coagulation cascade and how will they impact thromboprophylaxis in a variety of clinical settings. Join Drs Turpie and Weitz as they discuss the limitations of existing therapies and new developments in finding a replacement.

CME provider: Medscape.
Supported by an educational grant from Bayer HealthCare AG and from Ortho-McNeil, Inc, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc, administered by Ortho-McNeil-Janssen Scientific Affairs, LLC.

Steering committee

The steering committee members are active in overseeing the development and direction of this educational series.

Samuel Z Goldhaber, MD
Bengt L Eriksson, MD
Alexander G G Turpie, MD
Robert Harrington, MD
Jeffery L Weitz, MD
Richard J Friedman, MD

More information »

Previews

Featured CME

View all CME programs >>

We comply with the HONcode standard
for trustworthy health information: verify here.

	Yes
	No